FDA Approved Love? Exploring MDMA's Psychedelic Journey
We're witnessing history in the making as MDMA is expected to be the first psychedelic approved by the FDA, potentially transforming how we treat mental health. This is a unique opportunity to hear from key figures deeply intertwined with MDMA's unlikely path from the dance floor to late-stage clinical trials to, potentially, the therapist's couch. We’ll take a captivating journey to explore just how this former party is making its way into so many of our lives as a uniquely therapeutic medicine.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Matthew Baggott, PhD
Tactogen
Julie Holland
MAPS / Palo Santo / Beckley
Rachel Nuwer
Freelance Journalist
Tim Schlidt
Palo Santo